Skip to main content

Closed

TVRD: Tvardi Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-200.6%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio2.25×

Tvardi Therapeutics, Inc.

TVRDNASDAQ·USD·Closed

Tvardi Therapeutics, Inc.

TVRDNASDAQ·USD·Closed

$2.10

+0.00%

$2.10

+$0.00 (0.00%)

52W Range

1thpctl

Volume

0.08×avg

Mkt Cap

19.70MUSD

P/E

-1.3TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.08×avg

Market Cap

19.70MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings